Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.

ABSTRACT:

Introduction

Survivors of SARS-CoV-2 pneumonia often develop persistent respiratory symptom and interstitial lung abnormalities (ILAs) after infection. Risk factors for ILA development and duration of ILA persistence after SARS-CoV-2 infection are not well described in immunocompromised hosts, such as cancer patients.

Methods

We conducted a prospective cohort study of 95 patients at a major cancer center and 45 patients at a tertiary referral center. We collected clinical and radiographic data during the index hospitalization for COVID-19 pneumonia and measured pneumonia severity using a semi-quantitative radiographic score, the Radiologic Severity Index (RSI). Patients were evaluated in post-COVID-19 clinics at 3 and 6 months after discharge and underwent comprehensive pulm

SUBMITTER: Noh S 

PROVIDER: S-EPMC10524033 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature